Abiopharma

New Form 8-K - AVITA Medical, Inc. Filed: 2025-08-18 AccNo: 0001762303-25-000026 Size: 151 KB Item 3.02: Unregistered Sales of Equity Securities

New Form 424B5 - BioXcel Therapeutics, Inc. Filed: 2025-08-18 AccNo: 0001104659-25-079882 Size: 34 KB

New Form 3 - BridgeBio Pharma, Inc. Filed: 2025-08-18 AccNo: 0000950170-25-109842 Size: 9 KB

New Form 144 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed: 2025-08-18 AccNo: 0001964306-25-000329 Size: 9 KB

New Form 8-K - BioXcel Therapeutics, Inc. Filed: 2025-08-18 AccNo: 0001104659-25-079880 Size: 216 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form S-8 - HYPERION DEFI, INC. Filed: 2025-08-18 AccNo: 0001104659-25-079875 Size: 196 KB

New Form 8-K - Catheter Precision, Inc. Filed: 2025-08-18 AccNo: 0001437749-25-027270 Size: 221 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 144 - Kiniksa Pharmaceuticals International, plc Filed: 2025-08-18 AccNo: 0001921094-25-000981 Size: 10 KB

New Form 8-K - REGENXBIO Inc. Filed: 2025-08-18 AccNo: 0000950170-25-109829 Size: 207 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

SHAW THOMAS J acquired 14.1k shares of RETRACTABLE TECHNOLOGIES INC (RVP) at average price $0.79 Filed: 2025-08-18 AccNo: 0001415889-25-022185 Size: 7 KB

Vohra Tajinder S adjusted position in 0.0 shares of REVVITY, INC. (RVTY) Filed: 2025-08-18 AccNo: 0000950170-25-109830 Size: 7 KB

New Form 8-K - PRECIGEN, INC. Filed: 2025-08-18 AccNo: 0000950103-25-010408 Size: 558 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 8-K - Bausch & Lomb Corp Filed: 2025-08-18 AccNo: 0001860742-25-000019 Size: 460 KB Item 1.02: Termination of a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: …

Podlesak Dennis adjusted position in 0.0 shares of Syndax Pharmaceuticals Inc (SNDX) at average price $15.84 Filed: 2025-08-18 AccNo: 0000950170-25-109815 Size: 20 KB

New Form SCHEDULE 13G - Structure Therapeutics Inc. Filed: 2025-08-18 AccNo: 0000921895-25-002329 Size: 38 KB